FINWIRES · TerminalLIVE
FINWIRES

Telix Enters Attractive Market With Late-Stage Brain Cancer Drug Trial in US, Jefferies Says

By

Telix (ASX:TLX) entered a potentially attractive market after the commencement of phase three trial for recurrent glioblastoma, a type of brain cancer, in the US, Jefferies said in a note on Wednesday.

The investment firm said that with around 20,000 patients diagnosed annually in the US with recurrent glioblastoma and limited treatment options, the market appears promising for its drug candidate TLX101-Tx.

Jefferies, however, gave a risk-weighted valuation to the experimental drug in Telix's overall valuation.

The brokerage boosted Telix's fiscal year 2026 net profit after tax estimate to $5.1 million from $3.3 million, driven by the inclusion of TLX101-Tx in its valuation, with first sales expected in fiscal year 2029, refinancing of $600 million in convertible bonds, and changes to assumptions for expenses and costs.

Jefferies kept a buy rating on Telix and raised its price target to AU$27.40 from AU$24.30.

Related Articles

Asia

Shenzhen Huaqiang Industry Forecasts Up to 120% Surge in Q1 Profit

Shenzhen Huaqiang Industry (SHE:000062) forecasts an 80% to 120% rise in its net attributable profit to between 190 million yuan and 232.3 million yuan in the first quarter from 105.6 million yuan in the year-ago period, according to a Wednesday filing with the Shenzhen bourse.The electronic information products maker attributed the expected rise to an increase in revenue from its storage products, with shipments surging 250% year over year, the filing said.Shares decreased 2% during the midday break on Wednesday.

$SHE:000062
Asia

Shanghai International Airport Logs Higher March Passenger Throughput

Shanghai International Airport (SHA:600009) reported higher passenger throughput at its two airports in March, according to a Wednesday filing with the Shanghai bourse.At the Pudong International Airport, passenger throughput rose 11% year over year to 7.4 million, while its cargo and mail throughput climbed 8.1% to 372,100 tons, and aircraft movements increased 4.7% to 47,395 flights.The Hongqiao International Airport saw a 6.1% year-on-year rise in passenger throughput to 4.4 million, while cargo and mail throughput inched up 0.3% to 35,700 tons, and aircraft movements increased 2.4% to 24,683 flights.

$SHA:600009
Asia

Hengyi Petrochemical's Q1 Profit Skyrockets 3,774%

Hengyi Petrochemical's (SHE:000703) net profit attributable to shareholders in the first quarter skyrocketed 3,774% to 1.99 billion yuan from 51.5 million yuan a year earlier, according to a Shenzhen bourse filing on Wednesday.Earnings per share surged 2,600% year on year to 0.54 yuan from 0.02 yuan.The petrochemical producer's operating revenue rose 10% to 29.9 billion yuan from 27.2 billion yuan in the prior year.

$SHE:000703